Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
FDA
Description:
The United States Food and Drug Administration, a federal agency responsible for regulating drugs, medical devices, food, and other health-related products.
Related topics:
Healthcare Regulation (16%),
Pharmaceutical Economics and Policy (10%),
Pharmacovigilance and Adverse Drug Reactions (8%)
Wikidata ID:
wiki/Q204711
OpenAlex ID:
keywords/fda
Liposome: classification, preparation, and applications
2013
·
Abolfazl Akbarzadeh
, Rogaie Rezaei-Sadabady
, et al.
·
Nanoscale Research Letters
·
3,851
PDF
Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015–20): a comparative analysis
2021
·
Urs J Muehlematter
, Paola Daniore
, et al.
·
The Lancet Digital Health
·
779
PDF
Center for Drug Evaluation and Research
2020
·
National Cancer Institute
·
Definitions
·
678
PDF
The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives
2020
·
Rachel Foulkes
, Ernest Man
, et al.
·
Biomaterials Science
·
606
PDF
Analytical Method Development and Validation
2018
·
Michael E. Swartz
, Ira S. Krull
·
CRC Press eBooks
·
550
Artificial intelligence and machine learning in clinical development: a translational perspective
2019
·
Pratik Shah
, Francis Kendall
, et al.
·
npj Digital Medicine
·
529
PDF
Women's Trials: The Approval of the First Oral Contraceptive Pill in the United States and Great Britain
2002
·
S. W. Junod
, Lara Marks
·
Journal of the History of Medicine and Allied Sciences
·
461
Continuous Processing in the Pharmaceutical Industry
2005
·
K. Plumb
·
Process Safety and Environmental Protection
·
458
European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria
2003
·
G. Kahlmeter
, Derek F J Brown
, et al.
·
Journal of Antimicrobial Chemotherapy
·
413
The need for a system view to regulate artificial intelligence/machine learning-based software as medical device
2020
·
Sara Gerke
, Boris Babic
, et al.
·
npj Digital Medicine
·
398
PDF
Final Report on the Safety Assessment of Benzyl Alcohol, Benzoic Acid, and Sodium Benzoate
2001
·
B Nair
·
International Journal of Toxicology
·
374
Live biotherapeutic products: the importance of a defined regulatory framework
2020
·
Magali Cordaillat-Simmons
, Alice Rouanet
, et al.
·
Experimental & Molecular Medicine
·
361
PDF
Developing the Sentinel System — A National Resource for Evidence Development
2011
·
Rachel E. Behrman
, Joshua S. Benner
, et al.
·
New England Journal of Medicine
·
335
Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems
1993
·
David A. Kessler
·
JAMA
·
322
Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A
2008
·
John Peterson Myers
, Frederick S. vom Saal
, et al.
·
Environmental Health Perspectives
·
310
Schemata, Distributions and Graphical Models in Evolutionary Optimization
1999
·
Heinz Mühlenbein
, Thilo Mahnig
, et al.
·
Journal of Heuristics
·
297
Government by Algorithm: Artificial Intelligence in Federal Administrative Agencies
2020
·
David Freeman Engstrom
, Daniel E. Ho
, et al.
·
SSRN Electronic Journal
·
292
Chirality of New Drug Approvals (2013–2022): Trends and Perspectives
2024
·
Rebecca U. McVicker
, Niamh M. O’Boyle
·
Journal of Medicinal Chemistry
·
286
Forced degradation of recombinant monoclonal antibodies: A practical guide
2017
·
Christine Nowak
, Jason K. Cheung
, et al.
·
mAbs
·
280
PDF
Antibiotic residues in poultry tissues and eggs: human health concerns?
2003
·
DJ Donoghue
·
Poultry Science
·
266
PDF
Perspectives on the Use of Data Mining in Pharmacovigilance
2005
·
June Almenoff
, Joseph M Tonning
, et al.
·
Drug Safety
·
258
Deuterated drugs draw heavier backing
2016
·
Asher Mullard
·
Nature Reviews Drug Discovery
·
257
The FDA's sentinel initiative—A comprehensive approach to medical product surveillance
2015
·
R Ball
, M Robb
, et al.
·
Clinical Pharmacology & Therapeutics
·
253
Adverse drug event monitoring at the food and drug administration
2003
·
Syed Rizwanuddin Ahmad
·
Journal of General Internal Medicine
·
248
The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology
2017
·
Daniel N Cagney
, Joohee Sul
, et al.
·
Neuro-Oncology
·
241
Show more works
View as search
Works count:
7,012
Citation count:
46,940
Year
Topic
Type